Anti-malaria MAb in Kenyan Children

NCT05400655 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

912

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection
Malaria

Interventions

DRUG: L9LS
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]